STAT

MARCH 14, 2024

Why don’t patients want gene therapy? We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease. What happens when an approved drug doesn’t work? And is MASH still a big deal?

Drug Development 296

Drug Development 296

STAT

APRIL 2, 2024

Verve Therapeutics said Tuesday that it is pausing testing of its closely watched gene-editing treatment for high cholesterol after a patient receiving the drug experienced elevated liver enzymes and low platelet levels.

Compounding 298

Compounding 298

STAT

MARCH 8, 2024

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work.

Drug Development 362

Drug Development 362

STAT

MAY 6, 2024

“Steward does not expect any interruptions in its day-to-day operations, which will continue in the ordinary course throughout the [bankruptcy] process,” it said in a news release posted at 3:27 a.m. ” Continue to STAT+ to read the full story…

Hospitals 242

Hospitals 242

STAT

MARCH 14, 2024

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week?

311

311

STAT

AUGUST 24, 2023

News & World Report   recently issued its 2023-24 Best Hospitals ratings. News process, while some hospitals have expressed their desire to abandon the rankings as well. Now is the time for health care ratings to offer patients transparent and useful measures of quality that enable informed choices.

Hospitals 245

Hospitals Medical Schools 245

STAT

APRIL 26, 2024

Or you could hold your breath and spend time catching up on the news of the world. … Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S. Overall, antibiotic use did not improve clinical outcomes for patients with Covid-19.

Biosimilars 282

Biosimilars Specialty Pharmacies Hospitals 282

STAT

DECEMBER 9, 2023

SAN DIEGO — News of the Food and Drug Administration’s historic approval of the first gene therapies for sickle cell disease sparked discussion, debate, and, above all, measured optimism at this year’s meeting of the American Society of Hematology. Jude Children’s Research Hospital. I remain skeptical.”

Hospitals 346

Hospitals 346

STAT

DECEMBER 12, 2023

When Sanofi terminated its partnership with Maze Therapeutics this week to develop an experimental drug for Pompe disease, Maze CEO Jason Coloma did not learn the news in a conference call with the French pharma giant or even an email. He found out when Sanofi issued a public statement. Responding to the U.S.

299

299

STAT

DECEMBER 1, 2023

Sometimes it takes days, or even weeks, for medical imaging results to be analyzed by a radiologist, transferred to a primary doctor, and then delivered to the patient — good news or bad. Today, that hand-wringing delay has been nearly eliminated.

283

283

STAT

NOVEMBER 13, 2023

The news that the U.K. But the fact that a patient in her breast cancer prevention clinic hadn’t ever heard of such a possibility before was. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster.

350

350

STAT

NOVEMBER 17, 2023

This article is part of a partnership between First Opinion and Tradeoffs, a nonprofit news organization exploring our confusing, costly, and often counterintuitive health care system. To Manchester Memorial had to ask ambulances to take emergency patients elsewhere. What happened next is the stuff of nightmares.

Hospitals 304

Hospitals 304

STAT

NOVEMBER 28, 2023

Investors , analysts, doctors, and even patients face an avalanche of news from biotech companies about their human trials of experimental drugs, and wading through all that data to draw reasonable conclusions is a challenging task.

Drug Development 343

Drug Development 343

STAT

MAY 3, 2023

That’s very good news for a company that’s racing to reach more patients in hopes of building a sustainable business. Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment for attention deficit hyperactivity disorder is effective for adults.

260

260

STAT

APRIL 24, 2024

Today we have some developments about Novo Nordisk’s insulin business, a side of the company that people don’t really talk about anymore, and some news about their GLP-1 business, a side that people can’t stop talking about. Good morning! Adjusted earnings were $3.67 on total revenue of $2.29

Diabetes 291

Diabetes 291

STAT

APRIL 20, 2023

Our colleague Helen Branswell joins us to explain the latest news on Covid-19 boosters and the implications of a Marburg outbreak in Equatorial Guinea. Then we dive into the long history of a gene therapy from Sarepta Therapeutics, a polarizing medicine that promises to change the lives of patients with Duchenne muscular dystrophy.

Vaccines 246

Vaccines 246

STAT

SEPTEMBER 22, 2023

At the height of the pandemic, when everything was shut down, a patient with whom I had a long-term relationship developed suicidal ideation. The good news was that I could still have used this bricked phone to call 911 in the event of an emergency. And he was ashamed to use his parents’ telephone because of privacy issues.

343

343

STAT

JUNE 21, 2023

Last year, after a string of high-profile trial failures , the Huntington’s disease community got positive news in the form of very early data from an experimental gene therapy for the rare neurodegenerative condition.

Drug Development 329

Drug Development 329

STAT

MAY 4, 2023

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Drug Pricing 253

Drug Pricing 253

STAT

MARCH 14, 2023

Wade, the news has been full of stories about patients crossing state lines in order to access reproductive care. “I had a patient travel all the way from Mississippi,” said Sarah Traxler, an OB-GYN in Minnesota, “only for me to have to say, ‘It’s not safe for me to see you here in this clinic.

Hospitals 251

Hospitals 251

STAT

SEPTEMBER 13, 2023

A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.

311

311

STAT

MARCH 17, 2023

The message went out to some patients and to all of the employees of his company’s clinics across nine states — what had, up until moments before, been one of the largest ketamine clinic chains in the country. To patients, the news came as a complete shock. To patients, the news came as a complete shock.

274

274

STAT

NOVEMBER 23, 2022

Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information through a tracking tool on their websites, prominent systems like UPMC, Advocate Aurora, and Duke Health are still contending with the resulting legal action.

Hospitals 256

Hospitals 256

STAT

FEBRUARY 20, 2023

Dan Brickey was stunned when he learned the news. The dramatic change was due to a decision by the drug’s manufacturer, Vertex Pharmaceuticals, to slash the amount of financial assistance that it offers to patients this year. Read the rest…

Drug Pricing 246

Drug Pricing 246

STAT

MARCH 17, 2023

health care system is facing a new and costly threat that will affect patient care and ultimately may lead to hospital closures : paying for and processing a torrent of medical record requests. The already beleaguered U.S.

HIPAA 254

HIPAA Medical Records Hospitals 254

STAT

JUNE 5, 2023

       The big news from the first few days is that the AstraZeneca drug Tagrisso cuts deaths in half when given to non-small cell lung cancer patients with an EGFR mutation after surgery. That means that over five years, one more patient out of every 10 would still be alive.  

Drug Pricing 244

Drug Pricing Drug Development 244

Pharma Times

DECEMBER 18, 2023

MCI patients had 25% lower levels of serotonin compared to healthy patients - News - PharmaTimes

131

131

STAT

NOVEMBER 10, 2023

WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another. Medicare officials last week announced its major annual update to the way the program pays physicians.

292

292

STAT

OCTOBER 31, 2022

Happy Halloween and onto the news: FDA advisers unanimously spurned an experimental drug for rare pediatric brain cancer, Endpoints News tells us. But that study had no control group, and the agency and the company disagreed sharply on whether it showed patients were really living longer than standard of care.

244

244

Pharma Times

SEPTEMBER 7, 2023

The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries - News - PharmaTimes

154

154

Pharma Times

NOVEMBER 6, 2023

The device successfully diagnosed COPD in patients with 90% accuracy - News - PharmaTimes

153

153

STAT

AUGUST 23, 2023

As a physician in Florida who specializes in treating leprosy, also known as Hansen’s disease, this case report was not “news” to us in the field: We have known for some time about endemic cases of leprosy. Leprosy is caused by infection with one of the bacteria from the Mycobacterium leprae complex.

246

246

STAT

OCTOBER 18, 2022

But news this month that it is not effective against a steadily climbing coronavirus strain sent health officials racing to game out other antibody options and convene a meeting with patient groups. Read the rest…

Immunity 260

Immunity Immunization Vaccines 260

Pharma Times

DECEMBER 8, 2023

One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses - News - PharmaTimes

Immunity 127

Immunity Immunization Vaccines 127

Pharma Times

JULY 3, 2023

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

152

152

Pharma Times

DECEMBER 18, 2023

Earlier diagnosis could increase patient survival rates by five years or more - News - PharmaTimes

128

128

STAT

DECEMBER 12, 2022

NEW ORLEANS – An experimental immunotherapy from Affimed for patients with advanced Hodgkin lymphoma has started to demonstrate long-lasting remissions that have, so far, eluded other treatments involving so-called natural killer cells.

246

246